Jennifer Hutchinson, Clinical Pharmacist, Boston, MA, Massachusetts General Hospital

JenniferHutchinsonPharmD, BCOP

Clinical Pharmacist Boston, MA

Oncology Pharmacy

Oncology Clinical Pharmacist - Breast Cancer

Jennifer Hutchinson is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Jennifer Hutchinson's full profile

Already have an account?

Hospital Affiliations

Education & Training

  • Massachusetts College of Pharmacy-BostonPharmD, 2017

Professional Memberships

Publications & Presentations

Journal Articles

  • New treatments for early stage and metastatic breast cancer  
    Hutchinson JA, Oncolytics Today, 10/2020
  • Pertuzumab-associated diarrhea in HER2/neu-positive breast cancer patients: A comparison of trials to actual practice.  
    Yankulina O, Zullo AR, Cabral SE, Huynh JP, Hutchinson JA, Lopresti ML, Fenton MA, Berard-Collins CM, Journal of Oncology Pharmacy Practice, 10/20/2019

Abstracts/Posters

  • Denosumab use for cancer in frail older adults: A national study
    JA Hutchinson, AR Zullo, CM Berard-Collins, JP Huynh, Hematology/Oncology Pharmacists Association, Fort Worth, TX, 4/2019
  • Denosumab use for cancer in frail older adults: A national study
    JA Hutchinson, AR Zullo, CM Berard-Collins, JP Huynh, American Society of Health-system Pharmacists, Anaheim, CA, 12/2018
  • Effect of beta blockers on progression of heart failure in patients diagnosed with acute myelogenous leukemia undergoing induction treatment with mitoxantrone
    JA Hutchinson, J Bednarik, American Society of Health-system Pharmacists, Orlando, FL, 12/2017

Lectures

  • Cardiotoxicity Management in Oncology 
    University of Rhode Island College of Pharmacy - Kingston, RI - 3/2019
  • Effect of beta blockers on progression of heart failure in patients diagnosed with acute myelogenous leukemia undergoing induction treatment with mitoxantrone 
    Eastern States Conference - Hershey, PA - 4/2018